Navy Special Medical Centre, Second Military Medical University, Shanghai, China.
Department of Pharmacy, Changzheng Hospital, Second Military Medical University, Shanghai, China.
Plant Biotechnol J. 2024 Jun;22(6):1536-1548. doi: 10.1111/pbi.14284. Epub 2024 Jan 16.
Salvianolic acids (SA), such as rosmarinic acid (RA), danshensu (DSS), and their derivative salvianolic acid B (SAB), etc. widely existed in Lamiaceae and Boraginaceae families, are of interest due to medicinal properties in the pharmaceutical industries. Hundreds of studies in past decades described that 4-coumaroyl-CoA and 4-hydroxyphenyllactic acid (4-HPL) are common substrates to biosynthesize SA with participation of rosmarinic acid synthase (RAS) and cytochrome P450 98A (CYP98A) subfamily enzymes in different plants. However, in our recent study, several acyl donors and acceptors included DSS as well as their ester-forming products all were determined in SA-rich plants, which indicated that previous recognition to SA biosynthesis is insufficient. Here, we used Salvia miltiorrhiza, a representative important medicinal plant rich in SA, to elucidate the diversity of SA biosynthesis. Various acyl donors as well as acceptors are catalysed by SmRAS to form precursors of RA and two SmCYP98A family members, SmCYP98A14 and SmCYP98A75, are responsible for different positions' meta-hydroxylation of these precursors. SmCYP98A75 preferentially catalyses C-3' hydroxylation, and SmCYP98A14 preferentially catalyses C-3 hydroxylation in RA generation. In addition, relative to C-3' hydroxylation of the acyl acceptor moiety in RA biosynthesis, SmCYP98A75 has been verified as the first enzyme that participates in DSS formation. Furthermore, SmCYP98A enzymes knockout resulted in the decrease and overexpression leaded to dramatic increase of SA accumlation. Our study provides new insights into SA biosynthesis diversity in SA-abundant species and versatility of CYP98A enzymes catalytic preference in meta-hydroxylation reactions. Moreover, CYP98A enzymes are ideal metabolic engineering targets to elevate SA content.
丹酚酸(SA),如迷迭香酸(RA)、丹参素(DSS)及其衍生物丹酚酸 B(SAB)等,广泛存在于唇形科和紫草科,由于其在制药工业中的药用特性而受到关注。过去几十年的数百项研究表明,4-香豆酰辅酶 A 和 4-羟基苯乳酸(4-HPL)是不同植物中迷迭香酸合酶(RAS)和细胞色素 P450 98A(CYP98A)亚家族酶参与合成 SA 的常见底物。然而,在我们最近的研究中,几种酰基供体和受体包括 DSS 及其酯化产物都在富含 SA 的植物中被确定,这表明以前对 SA 生物合成的认识是不够的。在这里,我们使用富含 SA 的代表性重要药用植物丹参来阐明 SA 生物合成的多样性。各种酰基供体和受体由 SmRAS 催化形成 RA 的前体,两个 SmCYP98A 家族成员 SmCYP98A14 和 SmCYP98A75 负责这些前体不同位置的间位羟化。SmCYP98A75 优先催化 C-3' 羟化,SmCYP98A14 优先催化 RA 生成中的 C-3 羟化。此外,与 RA 生物合成中酰基受体部分的 C-3' 羟化相比,SmCYP98A75 已被验证为第一个参与 DSS 形成的酶。此外,SmCYP98A 酶敲除导致 SA 积累减少,过表达导致 SA 积累显著增加。我们的研究为富含 SA 的物种中 SA 生物合成的多样性以及 CYP98A 酶在间位羟化反应中的催化偏好的多功能性提供了新的见解。此外,CYP98A 酶是提高 SA 含量的理想代谢工程靶标。